Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc.
Share · JP3549370009 (XTKS)
Overview
No Price
Closing Price XTKS 28.10.2025: 443,00 JPY
28.10.2025 05:44
Current Prices from Delta-Fly Pharma, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
4598.T
JPY
28.10.2025 05:44
443,00 JPY
-15,00 JPY
-3,28 %
Share Float & Liquidity
Free Float 77,35 %
Shares Float 8,45 M
Shares Outstanding 10,92 M
Company Profile for Delta-Fly Pharma, Inc. Share
Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. Delta-Fly Pharma, Inc. was incorporated in 2010 and is headquartered in Tokushima, Japan.
Get up to date insights from finAgent about Delta-Fly Pharma, Inc.

Company Data

Name Delta-Fly Pharma, Inc.
Company Delta-Fly Pharma, Inc.
Website https://www.delta-flypharma.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3549370009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Kiyoshi Eshima
Market Capitalization 8 Mrd.
Country Japan
Currency JPY
Employees 0,0 T
Address 37-5 Nishikino, 771-0116 Tokushima
IPO Date 2018-10-12

Ticker Symbols

Name Symbol
Tokyo 4598.T
More Shares
Investors who hold Delta-Fly Pharma, Inc. also have the following shares in their portfolio:
JPMorgan U.S. Equity Fund Class A
JPMorgan U.S. Equity Fund Class A Fund
ORACLE 21/41
ORACLE 21/41 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025